← Eichor
Study identifier: NCT07703371 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Kodo Millet Porridge and Its Effects on Gut Health and Metabolic Syndrome

Condition: Obesity & Overweight · Metabolic Syndrome · Gut Dysbiosis  ·  Sponsor: JSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH

PhaseNA
Planned participants50
Who can joinAll sexes, 20 Years to 60 Years
Healthy volunteersNo

About this study

Dietary fiber are components in foods that are not digested by human gastrointestinal enzymes (alpha amylase and alpha glucosidase) but are instead broken down and fermented by gut microbes. The byproducts generated during fermentation in the large intestine, primarily short-chain fatty acids (SCFA), bile acids, indoles, and their derivatives, circulate through the circulatory system to the liver, lungs, brain, adipose tissue, and muscles, where they modulate metabolism (suppress lipogenesis and alleviate insulin resistance) and immune function. Individuals who are overweight or obese frequently exhibit gut dysbiosis, characterized by lower SCFA producing commensals. This condition predisposes them to metabolic disorders such as insulin resistance, dyslipidemia, and hypertension, and contributes to conditions including type 2 diabetes, cardiovascular disease, and metabolic dysfunction-associated steatotic liver disease. Preclinical and clinical research have demonstrated that the consumption of fiber-rich foods maintains or restores gut microbiota health and diminishes the risk of metabolic disorders. Kodo millet (Paspalum scrobiculatum), a small millet, is rich in dietary fiber and we have developed a palatable kodo millet porridge beverage enriched with polyphenols and dietary fiber. The purpose of this study is to examine the effects of consuming Kodo millet porridge beverage as a nutritional supplement for 3 months, on gut microbiome richness (composition and diversity) a…

This description comes directly from the study's public registry record.

Talk to the study team

Prerana Shridhar Bhat, MSc  ·  +918762399079  ·  preranabhat@jssuni.edu.in

Dr. Rajesh Kumar Thimmulappa, PhD  ·  +91-9972012892  ·  rajeshkt@jssuni.edu.in

Always discuss trial participation with your own doctor first.

Locations (1)

JSS Medical College, JSS Academy of Higher Education & Research(JSSAHER).Mysore, Karnataka, IndiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07703371